BILLAS PASSED BY THE HOUSE H.237
2025 Page 1 of 11
1 H.237
2 Introduced by Representatives McFaun of Barre Town, Cina of Burlington,
3 Cordes of Bristol, Demar of Enosburgh, Galfetti of Barre Town,
4 Goldman of Rockingham, and Page of Newport City
5 Referred to Committee on
6 Date:
7 Subject: Professional regulation; health; doctoral-level psychologist;
8 prescribing
9 Statement of purpose of bill as introduced: This bill proposes to authorize
10 prescribing by doctoral-level psychologists.
11 An act relating to prescribing by doctoral-level psychologists
12 It is hereby enacted by the General Assembly of the State of Vermont:
13 Sec. 1. 26 V.S.A. § 3001 is amended to read:
14 § 3001. DEFINITIONS
15 As used in this chapter:
16 (1) “Practice of psychology” means rendering or offering to render to
17 individuals, groups, or organizations, for a consideration, any service
18 involving the application of principles, methods, and procedures of
19 understanding, predicting, and influencing behavior that are primarily drawn

BILLAS PASSED BY THE HOUSE H.237
2025 Page 2 of 11
1 from the science of psychology. The science of psychology includes
2 assessment, diagnosis, prevention, and amelioration of adjustment problems
3 and emotional and mental disorders of individuals and groups.
4 (2) “Psychologist” or “practicing psychologist” means a person who is
5 licensed to practice psychology under this chapter.
6 (3) “Psychologist-doctorate” means a person who is so licensed under
7 this chapter.
8 (4) “Psychologist-master” means a person who is so licensed under this
9 chapter.
10 (5) “Board” means the Board of Psychological Examiners established
11 under this chapter.
12 * * *
13 (12) “Collaborating practitioner” means a physician licensed to practice
14 medicine pursuant to chapter 23 or 33 of this title or other prescribing provider
15 as approved by the Board who generally prescribes prescription drugs for the
16 treatment of a mental health condition to the physician’s or prescribing
17 provider’s patients in the normal course of the physician’s or prescribing
18 provider’s medical practice.
19 (13) “Drug” means an agent related to the diagnosis, treatment, or
20 management of a mental, nervous, emotional, behavioral, cognitive, or
21 substance misuse disorder.

BILLAS PASSED BY THE HOUSE H.237
2025 Page 3 of 11
1 (14) “Prescribing psychologist” means a licensed, doctoral-level
2 psychologist who has undergone specialized training, has passed an
3 examination as determined by rule, and has received a current prescribing
4 specialty under section 3019 of this title that has not been revoked or
5 suspended by the Board.
6 (15) “Prescription drug” has the same meaning as in section 2022 of this
7 title.
8 (16) “Prescriptive authority” means the authority to prescribe or
9 discontinue prescription drugs. “Prescriptive authority” shall exclude the
10 authority to dispense, administer, or distribute prescription drugs.
11 Sec. 2. 26 V.S.A. § 3009a is amended to read:
12 § 3009a. POWERS AND DUTIES OF BOARD
13 (a) The Board shall adopt rules necessary to perform its duties under this
14 chapter, including rules that:
15 (1) specify educational and other prerequisites for obtaining licensure;
16 (2) explain complaint and appeal procedures to licensees, applicants,
17 and the public;
18 (3) explain continuing education requirements; and
19 (3) regulate prescribing psychologist licensees pursuant to section 3019
20 of this title, including the length of clinical rotations, appropriate instructional
21 settings, and prescribing authority; and

BILLAS PASSED BY THE HOUSE H.237
2025 Page 4 of 11
1 (4) explain how the Board shall investigate suspected unprofessional
2 conduct regulate collaborative practice agreements pursuant to section 3019 of
3 this title, including collaborating practitioner qualifications and annual
4 competency evaluations.
5 * * *
6 Sec. 3. 26 V.S.A. § 3019 is added to read:
7 § 3019. PRESCRIBING BY DOCTORAL-LEVELPSYCHOLOGISTS
8 (a) Prescribing psychologist license. A psychologist-doctorate may apply
9 to the Board for a prescribing psychologist license. The application shall be
10 made on a form approved by the Board, include the payment of any required
11 fees, and be accompanied by evidence satisfactory to the Board that the
12 applicant:
13 (1) holds a current license to practice psychology at the doctoral level in
14 the State;
15 (2) has successfully completed the following minimum educational and
16 training requirements either during the doctoral program required for licensure
17 under this section or in an accredited undergraduate or master-level program
18 prior to or subsequent to the doctoral program required under this section:
19 (A) a postdoctoral training program in psychopharmacology
20 accredited by the American Psychological Association or its successor; and

BILLAS PASSED BY THE HOUSE H.237
2025 Page 5 of 11
1 (B) two years of supervised practice for not less than 20 hours per
2 week in a clinical setting agreed upon by both the psychologist-doctorate and
3 collaborating practitioner;
4 (3) has completed a national certifying exam, as determined by rule; and
5 (4) meets all other requirements for obtaining a prescribing psychologist
6 license, as determined by rule.
7 (b) Criteria for prescribing medication.
8 (1) A written collaborative agreement is required for all prescribing
9 psychologists practicing under a prescribing psychologist license issued
10 pursuant to this section.
11 (2) The issuance of prescriptive authority by a collaborating
12 practitioner to a prescribing psychologist may only include prescription drugs
13 for the treatment of mental health conditions that the collaborating practitioner
14 generally provides to patients in the normal course of practice, except
15 prescriptive authority for the following shall not be authorized:
16 (A) patients who are less than 18 years of age or 80 years of age or
17 older; and
18 (B) patients during pregnancy.
19 (3) The collaborating practitioner shall file the collaborative agreement
20 with the Board and notice of any termination of the agreement.

BILLAS PASSED BY THE HOUSE H.237
2025 Page 6 of 11
1 (4) Issuance of prescribing authority for Schedule II through V
2 controlled substances shall identify the specific controlled substance by brand
3 name or generic name. Prescription or administration of a controlled
4 substance by injection shall not be allowed.
5 (c) Specialty by endorsements. The Director of the Board may, upon
6 payment of the required fee, grant a prescribing specialty without examination
7 if:
8 (1) the applicant holds active psychologist prescribing authority in
9 another U.S. or Canadian jurisdiction; and
10 (2) the requirements for psychologist prescribing authority in that
11 jurisdiction are, in the judgement of the Director, substantially equivalent to
12 the requirements of this section.
13 Sec. 4. EFFECTIVE DATES
14 (a) This section and Sec. 2 (power and duties of the Board) shall take effect
15 on July 1, 2025.
16 (b) All remaining sections shall take effect on July 1, 2026.
Sec. 1. 26 V.S.A. § 3001 is amended to read:
§ 3001. DEFINITIONS
As used in this chapter:
(1) “Practice of psychology” means rendering or offering to render to
individuals, groups, or organizations, for a consideration, any service

BILLAS PASSED BY THE HOUSE H.237
2025 Page 7 of 11
involving the application of principles, methods, and procedures of
understanding, predicting, and influencing behavior that are primarily drawn
from the science of psychology. The science of psychology includes
assessment, diagnosis, prevention, and amelioration of adjustment problems
and emotional and mental disorders of individuals and groups.
(2) “Psychologist” or “practicing psychologist” means a person who is
licensed to practice psychology under this chapter.
(3) “Psychologist-doctorate” means a person who is so licensed under
this chapter.
(4) “Psychologist-master” means a person who is so licensed under this
chapter.
(5) “Board” means the Board of Psychological Examiners established
under this chapter.
* * *
(12) “Collaborating practitioner” means a physician licensed to
practice medicine pursuant to chapter 23 or 33 of this title with a specialty in
psychiatry.
(13) “DSM” means the Diagnostic and Statistical Manual of Mental
Disorders current at the time of practice.
(14) “Drug” has the same meaning as in section 2022 of this title.

BILLAS PASSED BY THE HOUSE H.237
2025 Page 8 of 11
(15) “Prescribing psychologist” means a licensed, doctoral-level
psychologist who has undergone specialized training, has passed an
examination as determined by rule, and has received a current prescribing
specialty under section 3019 of this title that has not been revoked or
suspended by the Board.
(16) “Prescription drug” has the same meaning as in section 2022 of
this title.
(17) “Prescriptive authority” means the authority to prescribe or
discontinue prescription drugs solely for the purpose of diagnosing, treating,
or managing a condition recognized in the DSM. “Prescriptive authority”
excludes the authority to:
(A) dispense, administer, or distribute prescription drugs; and
(B) prescribe or discontinue prescription drugs for patients who are
less than 18 years of age, over 80 years of age, or pregnant.
Sec. 2. 26 V.S.A. § 3009a is amended to read:
§ 3009a. POWERS AND DUTIES OF BOARD
(a) The Board shall adopt rules necessary to perform its duties under this
chapter, including rules that:
(1) specify educational and other prerequisites for obtaining licensure;
(2) explain complaint and appeal procedures to licensees, applicants,
and the public;

BILLAS PASSED BY THE HOUSE H.237
2025 Page 9 of 11
(3) explain continuing education requirements; and
(3) regulate prescribing psychologist licensees pursuant to section 3019
of this title, including:
(A) the settings of clinical rotations; and
(B) prescriptive authority, including designation of conditions and
drugs excluded from that authority, as well as requirements for the prescribing
of particular drugs; and
(4) explain how the Board shall investigate suspected unprofessional
conduct regulate collaborative practice agreements pursuant to section 3019
of this title, including collaborating practitioner qualifications and annual
competency evaluations.
* * *
Sec. 3. 26 V.S.A. § 3019 is added to read:
§ 3019. PRESCRIBING BY DOCTORAL-LEVEL PSYCHOLOGISTS
SPECIALTY
(a) Prescribing psychologist specialty. A psychologist-doctorate may apply
to the Board for a prescribing psychologist specialty. The application shall be
made in a manner approved by the Board and include the payment of any
required fees.
(b) Specialty by examination. A psychologist-doctorate shall be eligible for
the prescribing specialty if the psychologist-doctorate:

BILLAS PASSED BY THE HOUSE H.237
2025 Page 10 of 11
(1) holds a current license to practice psychology at the doctoral level
in the State;
(2) has successfully completed a postdoctoral training program in
psychopharmacology designated by the American Psychological Association
or its successor;
(3) has completed clinical rotations over a total of not less than 14
months in not less than nine practice settings, to include psychiatry, pediatrics,
geriatrics, family medicine, internal medicine, emergency medicine, obstetrics
and gynecology, surgery, and one elective;
(4) has completed a national certifying exam, as determined by rule;
and
(5) meets all other requirements for obtaining a prescribing psychologist
specialty, as determined by rule.
(c) Criteria for prescribing medication.
(1) A written collaborative agreement is required for all prescribing
psychologists practicing under a prescribing psychologist specialty issued
pursuant to this section.
(2) The issuance of prescriptive authority by a collaborating
practitioner to a prescribing psychologist shall only include prescription drugs
for the treatment of mental health conditions that the collaborating
practitioner generally provides to patients in the normal course of practice.

BILLAS PASSED BY THE HOUSE H.237
2025 Page 11 of 11
(3) The collaborating practitioner shall file the collaborative agreement
with the Board and notice of any termination of the agreement.
(4) Issuance of prescribing authority for Schedule II through V
controlled substances shall identify the specific controlled substance by brand
name or generic name. Prescription or administration of a controlled
substance by injection shall not be allowed.
(d) Specialty by endorsement. The Director of the Board may, upon
payment of the any required fee, grant a prescribing specialty without
examination if:
(1) the applicant holds active psychologist prescribing authority in
another U.S. or Canadian jurisdiction; and
(2) the requirements for psychologist prescribing authority in that
jurisdiction are, in the judgement of the Director, substantially equivalent to
the requirements of this section.
Sec. 4. EFFECTIVE DATES
(a) This section and Sec. 2 (power and duties of the Board) shall take effect
on July 1, 2025.
(b) All remaining sections shall take effect on July 1, 2026.

[DELETED: LASPDBYTEHEH5Pe1of1HIdbyRsMnofBeT,CaofBCsofB,DrofE,GiofBeTGnofR,adPeofNtCRdtoCeoDS:Plr;h;dlppStofpeofblasi:Tsblpstoa0pgbydlp1Anatrgtopgbydlp2ItishyedbyteGlAyofteSeofV3S.1.26V.§1isadtor4§3.D5Asudintsc6()“eofp”msrgorogtorrt7i,g,oro,frac,ays8igteanofp,m,adpso9u,p,adigbrttaepyd]
[DELETED: LASPDBYTEHEH5Pe2of1fmteseofp.Teseofpyia,d,p,adanofatpadeladmldsofisadg()“”or“gp”msapnwoildtopepyurtsc()“”msapnwoissoldutsc()“”msapnwoissoldurtc0()“”msteBdofPlEse1urtsc2**3()“gp”msapnldtop4mepttocr23or33oftsteororpgp5asadbyteBdwogypspndsfrt6ttofamlhhcntotepsorp7pspsintenlceoftepsorp8psmlp9()“”msanatrdtoted,t,o0mtofam,n,e,b,c,o1semed]
[DELETED: LASPDBYTEHEH5Pe3of1()“gp”msal,dptwohsuesdt,hspdaenasddbyr,adhsrdactpsyursn39oftstetthsntbnrdosdbyteB()“nd”hstesemgasinsn22oftt()“ea”msteaytopeodepnd.“ea”sleet0aytod,a,ordepnd1S.2.26V.§aisadtor2§3.PSADDSOFB3()TeBdslatrsnytopmisdsurt4c,igrst5()syeladorpsfrogl6()enctadalpstol,a7adtep8()encgenr;a9()repgptlspttosn30oftst,igtelhofclr,aei1s,adpga;a]
[DELETED: LASPDBYTEHEH5Pe4of1()enhwteBdsliesductrecepeaspttosn39otst,igcgprqsadacye**S.3.26V.§9isadtor§.PGBYDLP()Pgptl.ApemyatoteBdfrapgptl.Teanslb0meonafmadbyteB,ieteptofayr1f,adbeadbyeesytoteBdttt2a3()hsactletopepyattedllli4teS5()hssycdtefgmmela6tgrserdgtedlpmrdfrl7urtssnorinanadueormlp8prtoorsttotedlpmrdurtss9()apltgpminp0adbyteAnPlAnoriss;a]
[DELETED: LASPDBYTEHEH5Pe5of1()toysofsdpefrntlstn20hspwkinaclsgadunbybhtepeacgp()hscdanlcge,asddbyr;a()msalorrsfrogapgpl,asddbyr()Cafrpgm()Awnceatisrdfralppspgurapgptlei0pttotss1()Teieofpeaybyac2prtoapgptmyoyiepnd3frtettofmlhhcstttecgp4gypstopsintenlceofp,e5peayfrtefgslntbea6()pswoaelstn18ysofaeor80ysofaeo7o;a8()psdgp9()Tecgprslfetecea0whteBdadneofaytnoftea]
[DELETED: LASPDBYTEHEH5Pe6of1()IeofpgayfrSeIIthcdsssliytesccdsebybneorgcn.Pnoranofacsebyinslntbea()Sybye.TeDrofteBdm,uptofterdf,gtapgsywtei()teathsaeptpgayiarU.orCnj;a0()tersfrptpgayint1jna,intejtofteD,syett2tersoftss3S.4.EED4()TssnadS.2(raddsofteB)sltee5onJy1,26()AlrgssslteetonJy1,2.1.26V.§1isadtor3.Dsudintsc)“eofp”msrgorogtorrt,g,oro,frac,ays]
[DELETED: LASPDBYTEHEH5Pe7of1gteanofp,m,adpso,p,adigbrttaepydmteseofp.Teseofpyi,d,p,adanofatpdeladmldsofisadg)“”or“gp”msapnwoidtopepyurtsc)“”msapnwoissoldusc)“”msapnwoissoldurt)“”msteBdofPlEsertsc*)“gp”msapnldtemepttocr23or33oftstewhasyi)“”msteDcadSlMlofMsctatteteofp)“”hstesemgasinsn22oftst]
[DELETED: LASPDBYTEHEH5Pe8of1)“gp”msal,dtwohsuesdt,hspdanasddbyr,adhsrdactpyursn39oftstetthsntbnrdodbyteB)“nd”hstesemgasinsn22ost)“ea”msteaytopeoepndssyfrtepeofd,trmgacnrdinteD.“easteayt)d,a,ordepnd;a)peordepndsfrpswoastn18ysofa,or80ysofa,orp.2.26V.§aisadtor3.PSADDSOFB)TeBdslatrsnytopmisdsurt,igrst)syeladorpsfrogl)enctadalpstol,adtep]
[DELETED: LASPDBYTEHEH5Pe9of1)encgenr;a)repgptlspttosn3ftst,i)tessofclr;a)pea,igdnofcsasedfmtta,aswlasrsfrtepfprd;a)enhwteBdsliesdutrecepeaspttosn3ftst,igcgprqsadaye*.3.26V.§9isadtor.PGBYDLP)Pgpts.ApemyaoteBdfrapgpts.TeanslbeinamradbyteBdadieteptofadf)Sybye.Apeslbeeefepgsyiftep]
[DELETED: LASPDBYTEHEH5Pe10of1)hsactletopepyattedllnteS)hssycdapltgpmiyddbyteAnPlAriss)hscdclrsoratlofntlstn1sinntlstnnepes,toiep,p,fym,ilm,eym,odg,s,adoee)hscdanlcge,asddbyr)msalorrsfrogapgp,asddbyr)Cafrpgm)Awnceatisrdfralpspgurapgptsyittotss)Teieofpeaybyacrtoapgptsloyiepndrtettofmlhhcstttecrgypstopsintenlceofp]
[DELETED: LASPDBYTEHEH5Pe11of1)TecgprslfeteceahteBdadneofaytnoftea)IeofpgayfrSeIIthdsssliytesccdsebybeorgcn.Pnoranofacebyinslntbea)Sybye.TeDrofteBdm,utofteayrdf,gtapgsywni)teathsaeptpgayirU.orCnj;a)tersfrptpgayintna,intejtofteD,syettersoftss.4.EED)TssnadS.2(raddsofteB)slteenJy1,2)AlrgssslteetonJy1,2]